Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples